Thursday, March 27, 2014

FXR is a molecular target for the effects of vertical sleeve gastrectomy : Nature : Nature Publishing Group

http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13135.html

Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities.

---Steve

No comments: